Mitchell P. Kopin 13D/13G Filings for Agile Therapeutics, Inc. (AGRX)

Mitchell P. Kopin 13D and 13G filings for Agile Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-08
06:06 am
Sale		 2022-12-31 13G Agile Therapeutics, Inc.
AGRX		 Mitchell P. Kopin 54,600
6.300%		 -14,007decrease
(-20.42%)		 Filing
2022-07-11
06:06 am
Purchase		 2022-07-01 13G Agile Therapeutics, Inc.
AGRX		 Mitchell P. Kopin 68,607
9.990%		 68,607increase
(New Position)		 Filing